Human NK Cells Display Important Antifungal Activity against Aspergillus fumigatus, Which Is Directly Mediated by IFN-γ Release
暂无分享,去创建一个
H. Einsele | O. Kurzai | J. Loeffler | F. Ebel | C. Morton | M. Bouzani | M. Ok | A. McCormick | Oliver Kurzai
[1] J. Latgé,et al. Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. , 2011, The Journal of infectious diseases.
[2] F. Ebel,et al. Aspergillus fumigatus: contours of an opportunistic human pathogen , 2010, Cellular microbiology.
[3] Sandra Bruns,et al. Interaction of phagocytes with filamentous fungi. , 2010, Current opinion in microbiology.
[4] B. Beutler,et al. NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. , 2009, Blood.
[5] M. Burdick,et al. Early NK Cell-Derived IFN-γ Is Essential to Host Defense in Neutropenic Invasive Aspergillosis1 , 2009, The Journal of Immunology.
[6] R. Strieter,et al. Early NK Cell-Derived Interferon-Gamma Is Essential to Host Defense in Neutropenic Invasive Aspergillosis. , 2009, ATS 2009.
[7] J. Latgé,et al. Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms , 2009, BMC Microbiology.
[8] M. Cesari,et al. Interferon-γ and Granulocyte-Macrophage Colony Stimulating Factor Therapy in Three Patients with Pulmonary Aspergillosis , 2008, Infection.
[9] J. Heesemann,et al. Characterisation of the phagocytic uptake of Aspergillus fumigatus conidia by macrophages. , 2008, Microbes and infection.
[10] M. D'Ombrain,et al. The role of leukocytes bearing Natural Killer Complex receptors and Killer Immunoglobulin-like Receptors in the immunology of malaria. , 2007, Current opinion in immunology.
[11] J. Gavilanes,et al. Fungal ribotoxins: molecular dissection of a family of natural killers. , 2007, FEMS microbiology reviews.
[12] A. Safdar. Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections , 2006, Bone Marrow Transplantation.
[13] D. Denning,et al. Cytokine profiling of pulmonary aspergillosis , 2006, International journal of immunogenetics.
[14] H. Kantarjian,et al. Recombinant interferon γ1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions , 2006, Cancer.
[15] A. Oxenius,et al. MyD88-Dependent IFN-γ Production by NK Cells Is Key for Control of Legionella pneumophila Infection1 , 2006, The Journal of Immunology.
[16] S. Holland,et al. Immunotherapy for fungal infections. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] H. Zhou,et al. Transient overexpression of γ interferon promotes Aspergillus clearance in invasive pulmonary aspergillosis , 2005 .
[18] Roland Contreras,et al. Human Antimicrobial Peptides: Defensins, Cathelicidins and Histatins , 2005, Biotechnology Letters.
[19] M. Colonna,et al. Phospholipase C-γ2 Is a Critical Signaling Mediator for Murine NK Cell Activating Receptors1 , 2005, The Journal of Immunology.
[20] D. Kontoyiannis,et al. The safety of interferon‐γ‐1b therapy for invasive fungal infections after hematopoietic stem cell transplantation , 2005 .
[21] M. Smyth,et al. Activation of NK cell cytotoxicity. , 2005, Molecular immunology.
[22] J. Hanna,et al. Novel APC-like properties of human NK cells directly regulate T cell activation , 2015, bioRxiv.
[23] A. Krensky,et al. NK Cells Use Perforin Rather than Granulysin for Anticryptococcal Activity1 , 2004, The Journal of Immunology.
[24] B. Morrison,et al. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. , 2003, The Journal of clinical investigation.
[25] R. Koup,et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.
[26] J. Latgé,et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. , 2002, Blood.
[27] Andreas Peschel,et al. Chemokines Meet Defensins: the Merging Concepts of Chemoattractants and Antimicrobial Peptides in Host Defense , 2002, Infection and Immunity.
[28] Diego Piccioli,et al. Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells , 2002, The Journal of experimental medicine.
[29] M. Burdick,et al. Cutting Edge: IFN-Inducible ELR− CXC Chemokines Display Defensin-Like Antimicrobial Activity1 , 2001, The Journal of Immunology.
[30] J. Brieland,et al. Cytokine Networking in Lungs of Immunocompetent Mice in Response to Inhaled Aspergillus fumigatus , 2001, Infection and Immunity.
[31] Li Wc. Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases. , 2001 .
[32] C. Hu,et al. Synergistic Cytotoxicity of Rana catesbeiana Ribonuclease and IFN-γ on Hepatoma Cells , 2001 .
[33] M. Caligiuri,et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. , 1999, Journal of immunology.
[34] T. Standiford,et al. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. , 1999, Journal of immunology.
[35] D. Stevens,et al. Combination immunotherapy and antifungal chemotherapy. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] J. Latgé,et al. Th1 and Th2 cytokines in mice with invasive aspergillosis , 1997, Infection and immunity.
[37] Hongyung Choi,et al. Interferon-γ and Tumor Necrosis Factor-α Protect Mice from Invasive Aspergillosis , 1995 .
[38] T. Meshulam,et al. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). , 1995, The Journal of infectious diseases.
[39] H. Malech,et al. In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. , 1991, The Journal of infectious diseases.
[40] R. Friedman,et al. Interferon inhibits Aspergillus fumigatus growth in mice: an activity against an extracellular infection. , 1988, Journal of interferon research.
[41] Eric O Long,et al. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. , 2006, Blood.
[42] Lewis L Lanier,et al. NK cell recognition. , 2005, Annual review of immunology.
[43] M. Colonna,et al. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. , 2005, Journal of immunology.
[44] Y. Zhang,et al. Transient overexpression of gamma interferon promotes Aspergillus clearance in invasive pulmonary aspergillosis. , 2005, Clinical and Experimental Immunology.
[45] D. Kontoyiannis,et al. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. , 2005, Cancer.
[46] W. Liles. Immunomodulatory approaches to augment phagocyte-mediated host defense for treatment of infectious diseases. , 2001, Seminars in respiratory infections.
[47] J. J. Wang,et al. Synergistic cytotoxicity of Rana catesbeiana ribonuclease and IFN-gamma on hepatoma cells. , 2001, Biochemical and Biophysical Research Communications - BBRC.
[48] V. Kurup,et al. Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. , 1995, The Journal of infectious diseases.